207 related articles for article (PubMed ID: 24010907)
1. Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
Banks KP; Song WS
Radiol Clin North Am; 2013 Sep; 51(5):799-831. PubMed ID: 24010907
[TBL] [Abstract][Full Text] [Related]
2. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography for the diagnosis and management of patients with gastrointestinal malignancies.
Saga T; Nakamoto Y; Higashi T; Yoshikawa K
Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):479-93, ix. PubMed ID: 18674698
[TBL] [Abstract][Full Text] [Related]
4. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
Escott EJ
Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911
[TBL] [Abstract][Full Text] [Related]
5. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
6. PET/computed tomography and lymphoma.
Allen-Auerbach M; de Vos S; Czernin J
Radiol Clin North Am; 2013 Sep; 51(5):833-44. PubMed ID: 24010908
[TBL] [Abstract][Full Text] [Related]
7. PET/CT in gynecologic malignancies.
Brunetti J
Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
[TBL] [Abstract][Full Text] [Related]
8. Role of positron emission tomography/computed tomography in bone malignancies.
Peller PJ
Radiol Clin North Am; 2013 Sep; 51(5):845-64. PubMed ID: 24010909
[TBL] [Abstract][Full Text] [Related]
9. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Buchmann I; Ganten TM; Haberkorn U
Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
[TBL] [Abstract][Full Text] [Related]
10. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
11. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
13. [Roles of F-18 FDG PET or PET/CT for the evaluation of gastrointestinal malignancies].
Yun M; Kim BI
Korean J Gastroenterol; 2006 Dec; 48(6):378-87. PubMed ID: 17189920
[TBL] [Abstract][Full Text] [Related]
14. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
15. Role of positron emission tomography-computed tomography in pulmonary neoplasms.
Shreve P; Faasse T
Radiol Clin North Am; 2013 Sep; 51(5):767-79. PubMed ID: 24010905
[TBL] [Abstract][Full Text] [Related]
16. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).
Cameron K; Golan S; Simpson W; Peti S; Roayaie S; Labow D; Kostakoglu L
Abdom Imaging; 2011 Aug; 36(4):463-71. PubMed ID: 21465110
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.
Howard BA; Wong TZ
Radiol Clin North Am; 2021 Sep; 59(5):737-753. PubMed ID: 34392916
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal tract malignancies and positron emission tomography: an overview.
Esteves FP; Schuster DM; Halkar RK
Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
[TBL] [Abstract][Full Text] [Related]
19. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges.
Tind S; Vestergaard S; Farahani ZA; Hess S
Minerva Chir; 2017 Oct; 72(5):397-415. PubMed ID: 28565893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]